110 related articles for article (PubMed ID: 15311900)
1. [Consistent therapeutic success in osteoporosis].
Krankenpfl J; 2004; 42(3-4):100-1. PubMed ID: 15311900
[No Abstract] [Full Text] [Related]
2. [Update 2004. Osteoporosis--management--current status].
Bartl R
Krankenpfl J; 2004; 42(7-10):232. PubMed ID: 15675394
[No Abstract] [Full Text] [Related]
3. [Bisphosphonates in osteoporosis. Significantly reduces risk of fracture].
MMW Fortschr Med; 2001 May; 143(18):53. PubMed ID: 11393183
[No Abstract] [Full Text] [Related]
4. [When osteoporosis first manifests itself. Without therapy the next fracture threatens].
MMW Fortschr Med; 2002 Apr; 144(14):54. PubMed ID: 12014286
[No Abstract] [Full Text] [Related]
5. [What do we need to know--what can we do?].
Krankenpfl J; 2005; 43(7-10):217. PubMed ID: 16515289
[No Abstract] [Full Text] [Related]
6. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].
Adachi JD
MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719
[No Abstract] [Full Text] [Related]
7. [Faster and long-lasting protection with risedronate. With strengthened bones longer self-sufficient].
MMW Fortschr Med; 2004 May; 146(22):52-3. PubMed ID: 15373118
[No Abstract] [Full Text] [Related]
8. [Osteoporosis. Fracture as alarm signal].
MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
[No Abstract] [Full Text] [Related]
9. [To treat effectively without delay. The data on fractures decisive].
MMW Fortschr Med; 2003 May; 145(21):56-7. PubMed ID: 12845873
[No Abstract] [Full Text] [Related]
10. [Routine osteoporosis therapy].
Ringe JD
Krankenpfl J; 2004; 42(7-10):233. PubMed ID: 15675395
[No Abstract] [Full Text] [Related]
11. [Osteoporosis management in general practice. Preventing spontaneous bone fractures].
MMW Fortschr Med; 2010 Jul; 152(25-27):54-5. PubMed ID: 20672666
[No Abstract] [Full Text] [Related]
12. [A new bisphosphonate. A vertebral body fracture seldom remains alone].
MMW Fortschr Med; 2000 Jul; 142(26-27):55. PubMed ID: 10929492
[No Abstract] [Full Text] [Related]
13. Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
Can Fam Physician; 2003 Apr; 49():487. PubMed ID: 12729244
[No Abstract] [Full Text] [Related]
14. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date.
Hodsman AB; Hanley DA; Josse R
CMAJ; 2002 May; 166(11):1426-30. PubMed ID: 12054412
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.
Boonen S; McClung MR; Eastell R; El-Hajj Fuleihan G; Barton IP; Delmas P
J Am Geriatr Soc; 2004 Nov; 52(11):1832-9. PubMed ID: 15507059
[TBL] [Abstract][Full Text] [Related]
16. Risedronate treatment and extended fracture protection in postmenopausal women.
Harris ST
Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
[No Abstract] [Full Text] [Related]
17. [Osteoporosis compounds in general practice. That is REAL: in routine practice the better choice].
MMW Fortschr Med; 2007 Mar; 149(13):50. PubMed ID: 17672400
[No Abstract] [Full Text] [Related]
18. [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years].
MMW Fortschr Med; 2003 Jun; 145(23):59. PubMed ID: 12854232
[No Abstract] [Full Text] [Related]
19. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
20. [Risedronate treatment for osteoporosis].
Kishimoto H
Nihon Rinsho; 2004 Feb; 62 Suppl 2():419-22. PubMed ID: 15035163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
